Trial
NCT03743025
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Phase IVTERMINATEDSAFETYConfidence: HIGH
Sponsor
Emory University
Collaborators
National Institute of General Medical Sciences (NIGMS)
Condition
Stress Hyperglycemia
Intervention
Dulaglutide Injection
Why stopped
The study was terminated following the Data and Safety Monitoring Board (DSMB) review due to concerns with perioperative use of the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-30